Published in Cancer Weekly, June 22nd, 2010
"Many of them have been allowed to enter clinical trial. Due to the fact that these ingredients possess not only a comparatively high purity and quantity, but also a potential economic value, it seems that they are superior to and could replace fresh...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.